Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 1
2010 1
2012 1
2014 1
2015 1
2017 1
2018 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Auditory-evoked masseter inhibitory reflex.
Kiziltan ME, Benbir G, Uzun NA, Gökdemir S. Kiziltan ME, et al. Among authors: gokdemir s. Neurosci Lett. 2010 May 7;475(1):12-5. doi: 10.1016/j.neulet.2010.03.029. Epub 2010 Mar 17. Neurosci Lett. 2010. PMID: 20302911
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial.
Omma A, Batirel A, Aydin M, Yilmaz Karadag F, Erden A, Kucuksahin O, Armagan B, Güven SC, Karakas O, Gokdemir S, Altunal LN, Buber AA, Gemcioglu E, Zengin O, Inan O, Sahiner ES, Korukluoglu G, Sezer Z, Ozdarendeli A, Kara A, Ates I. Omma A, et al. Among authors: gokdemir s. Hum Vaccin Immunother. 2022 Nov 30;18(6):2122503. doi: 10.1080/21645515.2022.2122503. Epub 2022 Oct 31. Hum Vaccin Immunother. 2022. PMID: 36315843 Free PMC article. Clinical Trial.
The Effects of the Heat Shock Protein 90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin, Cannabinoid Agonist WIN 55,212-2, and Nitric Oxide Synthase Inhibitor Nω-Nitro-L-Arginine Methyl Ester Hydrochloride on the Serotonin and Dry Skin-Induced Itch.
Todurga Seven ZG, Tombulturk FK, Gokdemir S, Ozyazgan S. Todurga Seven ZG, et al. Among authors: gokdemir s. Int Arch Allergy Immunol. 2022;183(4):443-452. doi: 10.1159/000520509. Epub 2021 Dec 3. Int Arch Allergy Immunol. 2022. PMID: 34864727
Presentation of an unusual patient with Lafora disease.
Gökdemir S, Cağlayan H, Kızıltan M, Karaağaç N, Leblebici C, Yeni SN. Gökdemir S, et al. Epileptic Disord. 2012 Mar;14(1):94-8. doi: 10.1684/epd.2012.0489. Epileptic Disord. 2012. PMID: 22425593 Free article.
Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study.
Ates I, Batirel A, Aydin M, Karadag FY, Erden A, Kucuksahin O, Armagan B, Guven SC, Karakas O, Gokdemir S, Altunal LN, Buber AA, Gemcioglu E, Zengin O, Inan O, Sahiner ES, Korukluoglu G, Sezer Z, Ozdarendeli A, Omma A, Kara A. Ates I, et al. Among authors: gokdemir s. Vaccines (Basel). 2023 Jul 12;11(7):1234. doi: 10.3390/vaccines11071234. Vaccines (Basel). 2023. PMID: 37515050 Free PMC article.
A comparative ID migraine screener study in ophthalmology, ENT and neurology out-patient clinics.
Ertaş M, Baykan B, Tuncel D, Gökçe M, Gökçay F, Sirin H, Deniz O, Oztürk V, Idiman F, Karli N, Zarifoğlu M, Yildiz N, Siva A, Saip S, Göksan B, Ak F, Aluçlu U, Duman T, Melek IM, Bulut S, Berilgen S; MIRA-3 Study Group. Ertaş M, et al. Cephalalgia. 2009 Jan;29(1):68-75. doi: 10.1111/j.1468-2982.2008.01702.x. Epub 2008 Sep 2. Cephalalgia. 2009. PMID: 18771489
11 results